NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | |
---|---|---|---|---|---|---|
1 | 08:30-08:50 | 08:30-08:50 | Symposium |
The ECMO Research Networks: Observational Data and Platform Trials? |
Eddy Fan | |
2 | 08:50-09:10 | 08:50-09:10 | Symposium |
The ELSO Registry: Optimizing Quality in Your Program and a Path to Research |
Peter Rycus | |
3 | 09:10-09:30 | 09:10-09:30 | Symposium |
APELSO Registry - Harnassing Digital Transformations and Partnerships in Healthcare Research |
Pauline Yeung Ng | |
4 | 09:30-09:50 | 09:30-09:50 | Symposium |
Insight from the CSECLS Registry |
Chenglong Li | |
5 | 09:50-10:00 | 09:50-10:00 | Comment |
Discussion |
NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | |
---|---|---|---|---|---|---|
1 | 10:20-10:40 | 10:20-10:40 | Symposium |
How to Chose ECMO Configuration in ARDS Requiring Precannulation Hemodynamic Support |
Yonghao Xu | |
2 | 10:40-11:00 | 10:40-11:00 | Symposium |
Antimicrobial Exposures and Dosing in Critically Ill Patients Receiving ECMO |
Hafiz Abdul-Aziz | |
3 | 11:00-11:20 | 11:00-11:20 | Symposium |
How to Monitoring and Manage Neurological Functiong during ECMO |
Guangzhi Shi | |
4 | 11:20-11:40 | 11:20-11:40 | Symposium |
When and How to Decide to Withhold/withdraw Life-sustaining Therapy for OHCA Patients with ECPR? |
Hiromichi Naito | |
5 | 11:40-11:50 | 11:40-11:50 | Comment |
Discussion |
NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker |
---|---|---|---|---|---|
1 | 12:00-12:30 | 12:00-12:30 | Symposium |
Volume characteristics of ECMO patients |
Meng Xin |
NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker |
---|---|---|---|---|---|
1 | 12:40-13:10 | 12:40-13:10 | Symposium |
Applications and Prospects of Large Language Models in Critical Care Medicine |
Lei Jiang |
NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | |
---|---|---|---|---|---|---|
1 | 13:30-13:50 | 13:30-13:50 | Symposium |
Patient Selection Strategies in ECPR |
Akira Kawauchi | |
2 | 13:50-14:10 | 13:50-14:10 | Symposium |
Rational Approach to Hypoxemia on VV ECMO |
Bishoy Zakhary | |
3 | 14:10-14:30 | 14:10-14:30 | Symposium |
Optimal Timing of Tracheostomy in Patients on VV ECMO |
Keiki Shimizu | |
4 | 14:30-14:50 | 14:30-14:50 | Symposium |
The New Strategy for Left Ventricular Unloaing in VA-ECMO: Vena Caca Occlusion |
Shuanglei Li | |
5 | 14:50-15:00 | 14:50-15:00 | Comment |
Discussion |
NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | |
---|---|---|---|---|---|---|
1 | 15:10-15:20 | 15:10-15:20 | Symposium |
Circulatory Support for Cardiogenic Shock: ECMO |
Jae-Seung Jung | |
2 | 15:20-15:30 | 15:20-15:30 | Symposium |
Circulatory Support for Cardiogenic Shock: Impella |
Chengbin Zhou | |
3 | 15:30-15:40 | 15:30-15:40 | Comment |
Discussion |
NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker |
---|---|---|---|---|---|
1 | 15:40-15:48 | 15:40-15:48 | Symposium |
The Effect of Nitric Oxide on Inflammation and Coagulation in Neonates and Children Supported with Extracorporeal Membrane Oxygenation (ECMO) – Outcomes from a Prospective Randomized Trial |
Adrian Mattke |
2 | 15:48-15:56 | 15:48-15:56 | Symposium |
Efficacy of ECMO in Managing Suspected Fatal High-Risk Pulmonary Embolism and Prognostic Risk Factors in Confirmed Patients: An 11-Year Multicenter Retrospective Cohort Study |
Liusheng Hou |
3 | 15:56-16:04 | 15:56-16:04 | Symposium |
Exploration of the Clinical Assessment and Prognostic Value of SCAI Shock Staging in Patients with Acute Myocardial Infarction and Cardiogenic Shock Under VA-ECMO Support |
Kang Dong |
4 | 16:04-16:12 | 16:04-16:12 | Symposium |
In-hospital Outcomes of Extracorporeal Membrane Oxygenation Support after Pediatric Cardiac Surgery: A Nationwide Retrospective Cohort Study |
Xing Zhou |
5 | 16:12-16:20 | 16:12-16:20 | Symposium |
Global Research Trends and Hotspots in ECMO for Cardiogenic Shock: A Knowledge Mapping Approach |
Shanshan Chen |
6 | 16:20-16:28 | 16:20-16:28 | Symposium |
Population Pharmacokinetics of Intravenous Infusion of Hydromorphone in Critically Ill Patients Supported by Extracorporeal Membrane Oxygenation |
Xuehui Gao |
7 | 16:28-16:36 | 16:28-16:36 | Symposium |
The Relationship between Hemoglobin Level and Prognosis in Patients under VV ECMO Support |
Xinyi Luo |
8 | 16:36-16:44 | 16:36-16:44 | Symposium |
Impact of Early PaCO₂ and pH Fluctuations on Neurological Outcomes in ARDS Patients Receiving VV ECMO: A Retrospective Cohort Study from the CSECLS Registry |
Xiaoli Chen |
9 | 16:44-16:52 | 16:44-16:52 | Symposium |
Characterization of Pathogenic Bacterial Distribution in Extracorporeal Membrane Oxygenation-related Nosocomial Infections and the Prognostic Value of Early Inflammatory Biomarkers for Infection Survival |
Zhicheng Fang |
10 | 16:52-17:00 | 16:52-17:00 | Symposium |
Patients with Cardiogenic Shock Receiving Extracorporeal Membrane Oxygenation in Cardiac versus Non-cardiac Programs |
Xinrui Yu |
11 | 17:00-17:08 | 17:00-17:08 | Symposium |
Use of Extracorporeal Carbon Dioxide Removal in Hong Kong – a retrospective multicentered descriptive study |
Sheng Zhang |
12 | 17:08-17:16 | 17:08-17:16 | Symposium |
Gastric Mucosal Injury in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO): A Pilot Endoscopic Study |
Tingting Xiao |
13 | 17:16-17:24 | 17:16-17:24 | Symposium |
The myocardial viability assessment during VA-ECMO support by 18-fluorodeoxyglucose PET imaging |
Xing Fang |